Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?


YÜCEL S. , Akkaya E., Guntekin E., Kukul E., Danisman A., Akman S., ...Daha Fazla

UROLOGY, cilt.65, sa.2, ss.369-373, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objectives. To assess the clinical efficacy of tolterodine prescribed to children with non-neurogenic daytime urinary incontinence secondary to overactive bladder who had previously failed to improve with oral oxybutynin treatment and its relation to the side-effect profile and compliance status.